Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jovana Milic and Marianna Meschiari.
Jovana Milic
Connection Strength
1.399
Marianna Meschiari
  1. The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study. PLoS One. 2021; 16(8):e0251378.
    View in: PubMed
    Score: 0.240
  2. Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia. AIDS Res Hum Retroviruses. 2021 04; 37(4):283-291.
    View in: PubMed
    Score: 0.234
  3. Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19. Clin Exp Nephrol. 2021 Nov; 25(11):1203-1214.
    View in: PubMed
    Score: 0.060
  4. The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models. Open Forum Infect Dis. 2021 Jul; 8(7):ofab283.
    View in: PubMed
    Score: 0.060
  5. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering. J Healthc Eng. 2021; 2021:5556207.
    View in: PubMed
    Score: 0.060
  6. Acid base disorders in patients with COVID-19. Int Urol Nephrol. 2022 Feb; 54(2):405-410.
    View in: PubMed
    Score: 0.059
  7. Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients. Kidney Res Clin Pract. 2021 Jun; 40(2):231-240.
    View in: PubMed
    Score: 0.059
  8. Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1141.
    View in: PubMed
    Score: 0.058
  9. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
    View in: PubMed
    Score: 0.058
  10. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect. 2021 Aug; 27(8):1137-1144.
    View in: PubMed
    Score: 0.058
  11. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
    View in: PubMed
    Score: 0.058
  12. Hypokalemia in Patients with COVID-19. Clin Exp Nephrol. 2021 Apr; 25(4):401-409.
    View in: PubMed
    Score: 0.058
  13. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford). 2020 12 01; 59(12):e147-e150.
    View in: PubMed
    Score: 0.057
  14. Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency. PLoS One. 2020; 15(11):e0239172.
    View in: PubMed
    Score: 0.057
  15. Tocilizumab for severe COVID-19 pneumonia - Authors' reply. Lancet Rheumatol. 2020 Nov; 2(11):e660-e661.
    View in: PubMed
    Score: 0.056
  16. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia. Eur J Immunol. 2020 09; 50(9):1283-1294.
    View in: PubMed
    Score: 0.056
  17. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020 07 06; 11(1):3434.
    View in: PubMed
    Score: 0.056
  18. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.